CCL2 and central nervous system cancer: Glioma-bearing mice treated with duloxetine (a serotonin-norepinephrine reuptake inhibitor) exhibited a significant reduction in the level of chemokine CCL2/MCP-1 and prevented TAM infiltration into the tumor mass [208].